Dialogues in Cardiovascular Medicine - Vol 4 . No. 3 . 1999



Atheroma




The birth, growth, and consequences of the atherosclerotic plaque
M.J. Davies




Why does lipid lowering only reduce coronary heart disease events by half?
S.M. Cobbe


How can we identify patients at high risk of coronary heart disease events?
R.M. Califf


How can we stratify patients with unstable angina and determine optimal therapy?
A. Tonkin, D. Chew




M.R. Bennett


Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys
J.K. Williams and others

British Cardiac Society: 125I-labelled fibrinogen, autoradiography, and stereoarteriography in identification of coronary thrombotic occlusion in fatal myocardial infarction
W.F. Fulton, D.G. Sumner

Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion
E. Falk

Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis
L. Boring and others

Compensatory enlargement of human atherosclerotic coronary arteries
J. Kuusisto and others
Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content
M.J. Davies and others

Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis
M.T. Quinn and others

Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques
P.D. Richardson and others

Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man
S. Yla-Herttuala and others

Plaque fissures in human coronary thrombosis
P. Constantinides




© 2008 LES LABORATOIRES SERVIER, an incorporated company of SERVIER All Rights Reserved - Updates